Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-02 Sale |
2021-08-03 9:45 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
10,416 | $0.767 | $7,989 | 16,456,384 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:07 pm |
Verona Pharma plc | VRNA | Ullman Anders Director |
12,056 | $0.8397 | $10,123 | 334,856 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:07 pm |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
10,680 | $0.8397 | $8,968 | 105,320 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:06 pm |
Verona Pharma plc | VRNA | Cunningham Kenneth Director |
13,112 | $0.8397 | $11,010 | 66,584 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:05 pm |
Verona Pharma plc | VRNA | Sinha Vikas Director |
10,016 | $0.8397 | $8,410 | 74,440 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:04 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
11,184 | $0.8397 | $9,391 | 684,643 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:04 pm |
Verona Pharma plc | VRNA | Edwards Martin Director |
12,024 | $0.8397 | $10,097 | 111,064 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:03 pm |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
10,680 | $0.8397 | $8,968 | 73,080 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 4:06 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
52,056 | $0.8054 | $41,926 | 17,859,160 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 4:06 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
10,416 | $0.8731 | $9,094 | 16,921,640 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:05 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
26,728 | $1.1438 | $30,571 | 19,054,504 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:03 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
43,392 | $1.1437 | $49,627 | 20,050,848 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:11 pm |
Verona Pharma plc | VRNA | Ullman Anders Director |
10,800 | $0.9938 | $10,733 | 346,912 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:11 pm |
Verona Pharma plc | VRNA | Sinha Vikas Director |
10,224 | $0.9938 | $10,161 | 84,456 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:10 pm |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
10,800 | $0.9938 | $10,733 | 83,760 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:09 pm |
Verona Pharma plc | VRNA | Edwards Martin Director |
13,688 | $0.9938 | $13,603 | 123,088 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:09 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
11,912 | $0.9938 | $11,838 | 695,827 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:08 pm |
Verona Pharma plc | VRNA | Cunningham Kenneth Director |
13,104 | $0.9938 | $13,023 | 79,696 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-01 Tax Withholding |
2021-08-03 9:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
319,600 | $0.785 | 2,566,479 (Direct) |
View |
| 2021-08-01 Gift |
2021-08-03 9:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
360,400 | $0 | 2,566,479 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-03 9:45 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
454,840 | $0.785 | 16,456,384 (Direct) |
View |
| 2021-05-03 Tax Withholding |
2021-05-05 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
2,139,632 | $0.8875 | 17,859,160 (Direct) |
View |
| 2021-05-03 Tax Withholding |
2021-05-05 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
2,122,448 | $0.8875 | 16,921,640 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:02 pm |
N/A N/A |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
116,000 | $0 | 116,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 8:54 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
529,104 | $0 | 20,094,240 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 8:53 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
105,824 | $0 | 19,081,232 (Direct) |
View |
Ownership |
2021-01-05 7:28 pm |
N/A N/A |
Verona Pharma plc | VRNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner |
0 | $0 | 42,093,331 (Indirect) |
View |
Ownership |
2021-01-05 7:22 pm |
N/A N/A |
Verona Pharma plc | VRNA | Gupta Rishi Director 10% Owner |
0 | $0 | 42,093,331 (Indirect) |
View |
Ownership(A) |
2021-01-05 5:15 pm |
N/A N/A |
Verona Pharma plc | VRNA | Sinclair Andrew Director |
0 | $0 | 21,064,222 (Indirect) |
View |
Ownership |
2021-01-04 8:46 pm |
N/A N/A |
Verona Pharma plc | VRNA | Sonsini Peter W. 10% Owner |
0 | $0 | 42,638,131 (Indirect) |
View |
Ownership |
2021-01-04 8:45 pm |
N/A N/A |
Verona Pharma plc | VRNA | SANDELL SCOTT D 10% Owner |
0 | $0 | 42,638,131 (Indirect) |
View |
Ownership |
2021-01-04 8:45 pm |
N/A N/A |
Verona Pharma plc | VRNA | MAKOWER JOSHUA 10% Owner |
0 | $0 | 42,638,131 (Indirect) |
View |
Ownership |
2021-01-04 8:44 pm |
N/A N/A |
Verona Pharma plc | VRNA | Makhzoumi Mohamad 10% Owner |
0 | $0 | 42,638,131 (Indirect) |
View |
Ownership |
2021-01-04 8:44 pm |
N/A N/A |
Verona Pharma plc | VRNA | Florence Anthony A. Jr. 10% Owner |
0 | $0 | 42,638,131 (Indirect) |
View |
Ownership |
2021-01-04 8:43 pm |
N/A N/A |
Verona Pharma plc | VRNA | BASKETT FOREST 10% Owner |
0 | $0 | 42,638,131 (Indirect) |
View |
Ownership |
2021-01-04 8:43 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
0 | $0 | 3,847,152 (Direct) |
View |
Ownership |
2021-01-04 8:41 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
0 | $0 | 4,409,487 (Direct) |
View |
Ownership |
2021-01-04 8:39 pm |
N/A N/A |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
0 | $0 | 712,659 (Direct) |
View |
Ownership |
2021-01-04 8:37 pm |
N/A N/A |
Verona Pharma plc | RNA | Edwards Martin Director |
0 | $0 | 136,776 (Direct) |
View |
Ownership |
2021-01-04 8:29 pm |
N/A N/A |
Verona Pharma plc | VRNA | Sinha Vikas Director |
0 | $0 | 215,064 (Direct) |
View |
Ownership |
2021-01-04 8:27 pm |
N/A N/A |
Verona Pharma plc | VRNA | Ullman Anders Director |
0 | $0 | 357,712 (Direct) |
View |
Ownership |
2021-01-04 8:25 pm |
N/A 2030-09-24 |
Verona Pharma plc | VRNA | Sinclair Andrew Director |
0 | $0 | 185,600 (Direct) |
View |
Ownership |
2021-01-04 8:23 pm |
N/A N/A |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
0 | $0 | 94,560 (Direct) |
View |